Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Healthcare Costs
Fierce Healthcare
CMS delays Part D GLP-1 model amid skepticism from insurers
The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers.
Paige Minemyer
Apr 22, 2026 12:00pm
Fierce Healthcare
Bill to force payers to apply DTC drug purchases to deductibles
Apr 14, 2026 2:23pm
What’s ahead for biopharma and healthcare in 2026
Dec 19, 2025 10:00am
Fierce Healthcare
PhRMA launches ad campaign against '340B medicine mark-ups'
Sep 3, 2025 1:30pm
Fierce Healthcare
Eversana, Waltz Health to merge, unite drug pricing platforms
Aug 26, 2025 1:30pm
